| abstract |
The present invention relates to an anti-tumor composition, a pharmaceutical preparation for treating cancer and application thereof. The anti-tumor composition comprises a therapeutically effective amount of d-limonene, and myrcene and linalool for enhancing the therapeutic effect of d-limonene. alcohol, decanal and 3-carene. Compared with the prior art, the anti-tumor composition and the corresponding pharmaceutical preparation of the present invention have obvious proliferation inhibitory activity on tumor cells (especially lung cancer cells), and inhibit the migration and invasion of cells, and affect the levels of cancer cells-related proteins and genes. expression to promote tumor cell apoptosis. |